Rafe, in their investor letter they say that $8 million of their estimate for next quarter is revenue from the acquisition and not organic growth. That drops organic revenue down to $76 million, and organic growth rate to just under 29%.
https://investors.fastly.com/files/doc_financials/2020/q3/3Q…
With the successfully completed acquisition of Signal Sciences on October 1, 2020, our Q4 and FY2020 guidance includes the revenue contribution from Signal Sciences, which we expect to be approximately $8 million.
Saul